The patient, TABIOS, MARLIN, was admitted to the hospital with a diagnosis of congestive heart failure. Upon discharge, the patient was prescribed Atenolol 100 MG PO QD, Lasix (Furosemide) 40 MG PO QD, Reglan (Metoclopramide HCl) 10 MG PO TID, Coumadin (Warfarin Sodium) 3.75 MG PO QPM, Simvastatin 20 MG PO QHS, Insulin 70/30 (Human) 10 UNITS QAM; 0 UNITS QPM SC, Cozaar (Losartan) 100 MG PO QD, and Protonex (Pantoprazole) 40 MG PO QD, with a potentially serious interaction of Simvastatin and Warfarin. The patient was also instructed to follow a fluid restriction of two liters, a diet low in cholesterol and saturated fat, and a two gram Sodium diet. In addition, the patient was informed to take the Reglan with warm water, separately from other pills before meals and to avoid grapefruit unless instructed otherwise. The patient's insulin regiment was modified and the Beta Blocker was changed to once a day Atenolol, and she was instructed to switch to 10 units of 70/30 insulin the morning. The patient was put on a Full Code status and was discharged with instructions to walk as tolerated and to follow up with Asselmeier in 1-2 weeks and to arrange for INR to be drawn on 8/16/04 with follow up INR's to be drawn every 7 days. The patient was also advised to be aware of the potentially serious interaction between Simvastatin and Warfarin, discontinue Metoprolol and Lisinopril, start Cozaar and Atenolol, increase Reglan dose, and VNA for diabetes management, CHF management, and medical compliance.
Has the patient had previous insulin 70/30 ( human )
Insulin 70/30 (Human) 10 UNITS QAM; 0 UNITS QPM SC,